Intended consumersCommercial

Products 1 to 10 of 150

Biotech components: Bacteria
Business models: B2B
Country of production: USA
Country of distribution: USA + Sweden + Canada
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/08/30 11:49 (2 years ago)
Known funding amount: N/A
Funding types: Venture Capital
Industry: Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Input
Accellerase TRIO by DuPont + Genencor
Biotech components: Enzyme
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/09/20 09:09 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: Closed Production
Source: SynBio Database
Trading symbol: DWDP (NYSE)
Value chain stage: Input
Acrylic Acid by GC Innovation America + Myriant
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/10/02 15:42 (2 years ago)
Known funding amount: 110,000,000 USD
Funding types: Government + Venture Capital
Industry: Industrial
Market status: Early Stage Concept
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Input
Adipic Acid by Verdezyne
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/11/08 14:50 (2 years ago)
Known funding amount: 86,500,000 USD
Funding types: Venture Capital
Industry: Industrial
Market status: No longer on the market
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Biotech components: Bacteria
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/10/01 10:00 (2 years ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: Industrial
Market status: On the market
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
AquAdvantage Salmon (#1) by AquaBounty
Biotech components: Animal
Business models: B2C
Country of production: USA + Canada
Country of distribution: USA + Canada
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/08/30 11:49 (2 years ago)
Known funding amount: 28,300,000 USD
Funding types: Private Funding + Venture Capital
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Private Company
Product categories: Food
Production process: Open Release
Source: Web search
Trading symbol: AQB (NASDAQ)
Value chain stage: Finished Product
Arsenic Whole-cell Biosensors by Bielefield-CeBiTech
Biotech components: Bacteria
Business models: B2B + B2C
Country of production: Germany
Country of distribution: Germany
Intended consumer: Consumer + Commercial + Government
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/08/30 11:49 (2 years ago)
Known funding amount: N/A
Funding types: Government
Industry: Science
Market status: Early Stage Concept
Organization type(s): University + Research Institution
Product categories: Research
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
Artemisinic Acid by Amyris
Biotech components: Probiotic
Business models: B2B
Country of production: USA
Country of distribution: USA + Africa + France
Intended consumer: Commercial + Government
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/08/30 11:49 (2 years ago)
Known funding amount: 471,900,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: AMRS (NASDAQ)
Value chain stage: Input
Biotech components: Virus
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: Commercial + Government
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/08/30 11:49 (2 years ago)
Known funding amount: 27,400,000 USD
Funding types: Research Institution
Industry: Health
Market status: Under Development
Organization type(s): University + Research Institution
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Biotech components: Bacteria
Business models: B2B
Country of production: England
Country of distribution: England
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/08/30 11:49 (2 years ago)
Known funding amount: N/A
Funding types: Government
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): University + Research Institution
Product categories: Plant
Production process: Open Release
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input